<--- Back to Details
First PageDocument Content
Date: 2014-09-25 16:16:37

Final Results of a Phase 1b of Tarextumab (OMP-59R5) (anti-Notch2/3 antibody) in Combination with Nab-paclitaxel and Gemcitabine (Nab P+Gem) in Patients (pts) with Untreated Metastatic Pancreatic Cancer (mPC): ALPINE Stu

Add to Reading List

Source URL: s3.amazonaws.com

Download Document from Source Website

File Size: 874,68 KB

Share Document on Facebook

Similar Documents